Rijksinstituut voor Volksgezondheid en Milieu
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties. | RIVM
Bron:
rivm.nl